Cargando…
190P COVID-19 pandemic impact on lung cancer patient’s performance status and access to treatment: A comparative study pre and during COVID-19 era
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976191/ http://dx.doi.org/10.1016/j.annonc.2022.02.115 |
| _version_ | 1784680511177752576 |
|---|---|
| author | Fernandes, R. Pina, M. Fava Gaspar, C. Teixeira, A.R. Oliveira, C. Rodrigues, A. Azevedo, I. |
| author_facet | Fernandes, R. Pina, M. Fava Gaspar, C. Teixeira, A.R. Oliveira, C. Rodrigues, A. Azevedo, I. |
| author_sort | Fernandes, R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8976191 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89761912022-04-04 190P COVID-19 pandemic impact on lung cancer patient’s performance status and access to treatment: A comparative study pre and during COVID-19 era Fernandes, R. Pina, M. Fava Gaspar, C. Teixeira, A.R. Oliveira, C. Rodrigues, A. Azevedo, I. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2022-04 2022-04-02 /pmc/articles/PMC8976191/ http://dx.doi.org/10.1016/j.annonc.2022.02.115 Text en Copyright © 2022 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Fernandes, R. Pina, M. Fava Gaspar, C. Teixeira, A.R. Oliveira, C. Rodrigues, A. Azevedo, I. 190P COVID-19 pandemic impact on lung cancer patient’s performance status and access to treatment: A comparative study pre and during COVID-19 era |
| title | 190P COVID-19 pandemic impact on lung cancer patient’s performance status and access to treatment: A comparative study pre and during COVID-19 era |
| title_full | 190P COVID-19 pandemic impact on lung cancer patient’s performance status and access to treatment: A comparative study pre and during COVID-19 era |
| title_fullStr | 190P COVID-19 pandemic impact on lung cancer patient’s performance status and access to treatment: A comparative study pre and during COVID-19 era |
| title_full_unstemmed | 190P COVID-19 pandemic impact on lung cancer patient’s performance status and access to treatment: A comparative study pre and during COVID-19 era |
| title_short | 190P COVID-19 pandemic impact on lung cancer patient’s performance status and access to treatment: A comparative study pre and during COVID-19 era |
| title_sort | 190p covid-19 pandemic impact on lung cancer patient’s performance status and access to treatment: a comparative study pre and during covid-19 era |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976191/ http://dx.doi.org/10.1016/j.annonc.2022.02.115 |
| work_keys_str_mv | AT fernandesr 190pcovid19pandemicimpactonlungcancerpatientsperformancestatusandaccesstotreatmentacomparativestudypreandduringcovid19era AT pinam 190pcovid19pandemicimpactonlungcancerpatientsperformancestatusandaccesstotreatmentacomparativestudypreandduringcovid19era AT favagasparc 190pcovid19pandemicimpactonlungcancerpatientsperformancestatusandaccesstotreatmentacomparativestudypreandduringcovid19era AT teixeiraar 190pcovid19pandemicimpactonlungcancerpatientsperformancestatusandaccesstotreatmentacomparativestudypreandduringcovid19era AT oliveirac 190pcovid19pandemicimpactonlungcancerpatientsperformancestatusandaccesstotreatmentacomparativestudypreandduringcovid19era AT rodriguesa 190pcovid19pandemicimpactonlungcancerpatientsperformancestatusandaccesstotreatmentacomparativestudypreandduringcovid19era AT azevedoi 190pcovid19pandemicimpactonlungcancerpatientsperformancestatusandaccesstotreatmentacomparativestudypreandduringcovid19era |